J L Jorgensen

Suggest Changes
Learn More
PURPOSE The adverse prognosis of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia (ALL) prompted incorporation of monoclonal antibody therapy with rituximab(More)